BSECompany Update5d ago · 23 Jul 2026, 01:22 pm

Please find attached herewith Intimation regarding Resignation of Senior Management Personnel.

Alkem Laboratories Ltd · 539523

✦ AI SummaryMgmt Change

Alkem Laboratories Ltd has announced the resignation of Dr. Jitendra Singh Huda, a Senior Management Personnel, effective July 23, 2026, to pursue professional opportunities.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management

Attachments (1)

📄

9ee74d6f-e5cc-421f-92b8-7141346215fc.pdf

pdf

Download →
View document text
23rd July, 2026 The Corporate Relationship National Stock Exchange of India Department Limited BSE Limited Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Bandra East, Mumbai 400 001. Mumbai 400 051. Scrip Code: 539523 Scrip Symbol: ALKEM Sub: Disclosure under Regulation 30(2) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (“SEBI LODR Regulations”): Change in Senior Management Dear Sir(s)/Madam, Pursuant to Regulation 30 of SEBI LODR Regulations, we wish to inform you that Dr. Jitendra Singh Huda, a Senior Management Personnel has tendered his resignation from the services of the Company to pursue professional opportunities effective from 23rd July, 2026. Accordingly, Dr. Jitendra Singh Huda shall cease to hold Senior Management Position of the Company effective from the said date i.e 23rd July, 2026. The Company places on record appreciation for the valuable contribution made by him during his tenure as Senior Management Personnel of the Company. Further, the details as required in terms of Regulation 30 read with Schedule III of the SEBI LODR Regulations and SEBI Master Circular bearing No. HO/49/14/14(7)2025- CFDPOD2/I/3762/2026 dated January 30, 2026 is provided in Annexure I to this letter and a copy of resignation tendered by Dr. Jitendra Singh Huda is enclosed herewith as Annexure II. The above information is also available on the website of the Company at www.alkemlabs.com. Kindly take the same on your records. Sincerely, For Alkem Laboratories Limited Divya Mewani Vice President – Legal & Deputy Company Secretary Encl: a/a Annexure I (Disclosure in terms of Regulation 30 of the SEBI LODR Regulations read with SEBI Master Circular bearing Ref.No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026) Sr. No. Particulars Details 1. Reason for change viz. Resignation appointment, re-appointment, resignation, removal, death or otherwise 2. Date of appointment/ re- Dr. Jitendra Singh Huda shall cease to be appointment/ cessation (as Senior Management Personnel, effective applicable) and term of from 23rd July, 2026 appointment/ reappointment 3. Brief Profile Not Applicable 4. Disclosure of relationships Not Applicable between directors Outlook Annexure II FroRmaj:o rGsanhgiu li Sen1t5J: u 2l0y2 167 :38 ToJI:T ENDRAHSUIDNAG H CcS:a ncSh.iMtu ;rh ukdaarj it@XXX.com> SubjeRce: tR:e sigfnartotimhSo eren vc eis- ALKLEAMB ORATOLRTIDE S DeaDrrH uda, Notyeodu erm aWiela .cc epty ourre signaantidao,spn e yro urre quweisrltel,l iyeovouen 2 3rdJ uly 202P6el.a sbeei nto ucwhi tMhrS ancfhofirtu rtphreorc essy.o ufT ohyrao nuckro ntriabnuwdtii osnh yoaul tlh bee st. Regards, DrR ajoGrasnhgiu li PresiadneGdnl to bHaRHl e ad FroJmTI:E NDRASHUIDNAG H Sen14t Ju:l 2y0 2167 :19 ToR:a joGransguhlii CcS:a ncSh.iMtu ;rh kuadra jit SubjeRcets:i gfnoarmt thie Sorenvc eis-A LKELAMB ORATLOTRDI ES Deasri r, KeepPiorfnegsios nal Grow it nmhinadsd, i scuIas msr eeds;i fgrnoitmnhP geo osftS rV.PK .i ntdrle tyah tmiasai sl my forrmeasli gfnraottmhis eoe nr vices. Is hableal v aiilonaf bfiltceoce o mplaelttlhre ee sponsaindbp ielnidwtioinrtegkis t l h elen odf2 3rdo fJ u2l0y2 6. Thanfkofarulth lle s uppeoxrtte ndduermdiy nt ge nure. Iw oualld ls iotkore e uqesyto fuo arc cepmtaaoinfltc here e sigfnoafrtu irotfnhu etcruo rmem unications. Regards, DrJ.ei ntadS rinHguhda EmploNoy: e7e7 323